John Thomas, DO
Gastroenterology · Lincoln, NENPI 1265637151
Payments from drug & device makers
Across 322 payments — averaging $2911.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$928K
- Boston Scientific$5K
- Johnson & Johnson$805
- AbbVie$665
- Novo Nordisk$594
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$370
- plus $2K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 81 | $927,801 |
| Boston Scientific | 27 | $5,222 |
| Johnson & Johnson(2 entities) | 57 | $805 |
| AbbVie | 35 | $665 |
| Novo Nordisk | 7 | $594 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 20 | $370 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $338 |
| Janssen Scientific Affairs, LLC | 3 | $268 |
| Gilead | 10 | $186 |
| Aimmune Therapeutics, Inc. | 1 | $173 |
| Sanofi | 7 | $168 |
| Echosens North America, Inc. | 1 | $124 |
| Intercept Pharmaceuticals, Inc. | 6 | $91 |
| Bristol Myers Squibb | 5 | $82 |
| Merck | 5 | $78 |
| Olympus America Inc. | 1 | $70 |
| Pfizer | 5 | $68 |
| Madrigal Pharmaceuticals | 3 | $66 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
| Corcept Therapeutics | 1 | $60 |
| QOL Medical, LLC | 4 | $53 |
| Celltrion USA Inc. | 3 | $47 |
| Braintree Laboratories, Inc. | 3 | $45 |
| Lilly USA, LLC | 3 | $44 |
| Organon | 3 | $32 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Ironwood Pharmaceuticals, Inc | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $18 |
| Ardelyx, Inc. | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Apollo Endosurgery US Inc | 1 | $15 |
| Amgen | 1 | $14 |
How this compares
$937,632 in reported general payments places this provider in the 95th percentile of 89 gastroenterology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Lincoln
- Mark GriffinLincoln$7K
- David LeeLincoln$4K
- Clark AntonsonLincoln$4K
- Michael RothLincoln$3K
- Matthew HrnicekLincoln$3K
- Christopher RifeLincoln$3K
- Erik BowmanLincoln$3K
- Paul PetersenLincoln$3K
- Sally KnooihuizenLincoln$2K
- James RoatLincoln$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.